Kamil Zalewski
Overview
Explore the profile of Kamil Zalewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kacperczyk-Bartnik J, Khoptiana O, Zak K, Rajtak A, Shushkevich A, Pletnev A, et al.
Int J Gynecol Cancer
. 2025 Mar;
:101719.
PMID: 40032541
Objective: The Russian invasion of Ukraine in February 2022 caused a mass displacement of over 6 million people, including many women requiring urgent medical care, such as those with gynecologic...
2.
Rymuza J, Dlugosz A, Zalewski K, Kowalik A, Bujko M, Kowalewska M
Noncoding RNA
. 2025 Feb;
11(1).
PMID: 39997613
: Vulvar squamous cell carcinoma (VSCC) is a rare gynecologic malignancy, with most cases arising from differentiated vulvar intraepithelial neoplasia (dVIN). Approximately one-third of VSCC cases originate from high-grade squamous...
3.
Nikolova T, Bossart M, Kacperczyk-Bartnik J, Razumova Z, Strojna A, Bizzarri N, et al.
Front Oncol
. 2023 Jan;
12:1005130.
PMID: 36601477
Introduction: Gender-related differences in career development are well known issues in various professions. An international survey on gender-related differences was performed among young gynecologic oncology surgeons in Europe to identify...
4.
Strojna A, Kacperczyk-Bartnik J, Angeles M, Bizzarri N, van Ramshorst G, Theofanakis C, et al.
Int J Gynecol Cancer
. 2022 Nov;
32(12):1599-1605.
PMID: 36418053
No abstract available.
5.
Gomez-Hidalgo N, Pletnev A, Razumova Z, Bizzarri N, Selcuk I, Theofanakis C, et al.
Int J Gynaecol Obstet
. 2022 Aug;
160(1):306-312.
PMID: 35929452
Objective: To acquire a comprehensive assessment of the current status of implementation of Enhanced Recovery After Surgery (ERAS) protocols across Europe. Methods: The survey was launched by The European Network...
6.
Kacperczyk-Bartnik J, Nowosielski K, Razumova Z, Bizzarri N, Pletnev A, Lindquist D, et al.
Int J Gynecol Cancer
. 2022 May;
32(10):1309-1315.
PMID: 35568382
Objective: Both the location of primary disease and treatment side effects may have an impact on sexual function in oncogynecological patients. The aim of this study was to examine the...
7.
Bizzarri N, Pletnev A, Razumova Z, Zalewski K, Theofanakis C, Selcuk I, et al.
Int J Gynecol Cancer
. 2022 Jan;
32(4):494-501.
PMID: 34992130
Background: The European Society of Gynaecological Oncology (ESGO) and partners are committed to improving the training for gynecologic oncology fellows. The aim of this survey was to assess the type...
8.
Bujko M, Zalewski K, Szczyrek M, Kowalik A, Boresowicz J, Dlugosz A, et al.
Diagnostics (Basel)
. 2021 Sep;
11(9).
PMID: 34574047
Vulvar squamous cell carcinoma (VSCC) develops from high-grade squamous intraepithelial lesions (HSIL) and differentiated vulvar intraepithelial neoplasia (dVIN). This study aimed to assess the diagnostic value of circulating hsa-miR-431-5p in...
9.
Gaba F, Blyuss O, Rodriguez I, Dilley J, Wan Y, Saiz A, et al.
Int J Gynecol Cancer
. 2021 Jul;
31(9):1268-1277.
PMID: 34326158
Introduction: The SARS-CoV-2 global pandemic has caused a crisis disrupting health systems worldwide. While efforts are being made to determine the extent of the disruption, the impact on gynecological oncology...
10.
Cibula D, Borcinova M, Marnitz S, Jarkovsky J, Klat J, Pilka R, et al.
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34068399
Background: To prospectively assess LLL incidence among cervical cancer patients treated by uterine surgery complemented by SLN biopsy, without PLND. Methods: A prospective study in 150 patients with stage IA1-IB2...